Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kanerva

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|May 4, 2004
Modified adenoviruses for cancer gene therapyAnna Kanerva, Akseli Hemminki
Annals of Medicine|May 21, 2005
Adenoviruses for treatment of cancerAnna Kanerva, Akseli Hemminki
Expert Opinion on Biological Therapy|August 31, 2007
Gene therapy of gynaecological diseasesAnna Kanerva, Mari Raki, Akseli Hemminki
BMC Cancer|April 27, 2022
Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatmentKari Hemminki, Anna Kanerva, Asta Försti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2006
Gene transfer approaches for gynecological diseasesMari Raki, Daniel T Rein, Anna Kanerva, et al.
Plos One|October 4, 2018
Familial risks of ovarian cancer by age at diagnosis, proband type and histologyGuoqiao Zheng, Hongyao Yu, Anna Kanerva, et al.
Plos One|October 27, 2018
Correction: Familial risks of ovarian cancer by age at diagnosis, proband type and histologyGuoqiao Zheng, Hongyao Yu, Anna Kanerva, et al.
Plos One|April 16, 2013
Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropismAnniina Koski, Eerika Karli, Anja Kipar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 19, 2018
Borderline Ovarian Tumors Share Familial Risks with Themselves and Invasive CancersGuoqiao Zheng, Hongyao Yu, Anna Kanerva, et al.
Scientific Reports|August 3, 2018
Familial Ovarian Cancer Clusters with Other CancersGuoqiao Zheng, Hongyao Yu, Anna Kanerva, et al.
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|May 4, 2004
Modified adenoviruses for cancer gene therapyAnna Kanerva, Akseli Hemminki
Annals of Medicine|May 21, 2005
Adenoviruses for treatment of cancerAnna Kanerva, Akseli Hemminki
Expert Opinion on Biological Therapy|August 31, 2007
Gene therapy of gynaecological diseasesAnna Kanerva, Mari Raki, Akseli Hemminki
BMC Cancer|April 27, 2022
Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatmentKari Hemminki, Anna Kanerva, Asta Försti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2006
Gene transfer approaches for gynecological diseasesMari Raki, Daniel T Rein, Anna Kanerva, et al.
Plos One|October 4, 2018
Familial risks of ovarian cancer by age at diagnosis, proband type and histologyGuoqiao Zheng, Hongyao Yu, Anna Kanerva, et al.
Plos One|October 27, 2018
Correction: Familial risks of ovarian cancer by age at diagnosis, proband type and histologyGuoqiao Zheng, Hongyao Yu, Anna Kanerva, et al.
Plos One|April 16, 2013
Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropismAnniina Koski, Eerika Karli, Anja Kipar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 19, 2018
Borderline Ovarian Tumors Share Familial Risks with Themselves and Invasive CancersGuoqiao Zheng, Hongyao Yu, Anna Kanerva, et al.
Scientific Reports|August 3, 2018
Familial Ovarian Cancer Clusters with Other CancersGuoqiao Zheng, Hongyao Yu, Anna Kanerva, et al.
Pageof 13